America First Investment Advisors LLC lowered its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 87,734 shares of the financial services provider’s stock after selling 1,256 shares during the quarter. CME Group comprises about 5.2% of America First Investment Advisors LLC’s investment portfolio, making the stock its 5th biggest position. America First Investment Advisors LLC’s holdings in CME Group were worth $17,030,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Truvestments Capital LLC bought a new position in shares of CME Group during the 1st quarter valued at $32,000. Westside Investment Management Inc. bought a new position in CME Group in the 2nd quarter worth $38,000. Close Asset Management Ltd bought a new position in CME Group in the 1st quarter worth $34,000. Permanens Capital L.P. bought a new position in CME Group in the 1st quarter worth $41,000. Finally, Berman Capital Advisors LLC raised its holdings in CME Group by 23.9% in the 1st quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after acquiring an additional 66 shares during the period. Institutional investors and hedge funds own 84.58% of the company’s stock.
In other news, insider Hilda Harris Piell sold 1,132 shares of the business’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $188.05, for a total transaction of $212,872.60. Following the transaction, the insider now owns 33,011 shares in the company, valued at approximately $6,207,718.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Derek Sammann sold 6,400 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total transaction of $1,272,512.00. Following the transaction, the insider now owns 25,177 shares in the company, valued at approximately $5,005,942.91. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 78,873 shares of company stock worth $15,707,799. Insiders own 1.20% of the company’s stock.
Shares of CME opened at $208.89 on Thursday. The company has a market cap of $74.64 billion, a P/E ratio of 30.63, a PEG ratio of 4.58 and a beta of 0.23. CME Group Inc has a one year low of $161.05 and a one year high of $210.17. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The stock has a fifty day moving average price of $201.54.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the firm posted $1.74 EPS. The business’s revenue was up 20.1% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group Inc will post 6.66 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.44%. CME Group’s payout ratio is 43.99%.
CME has been the topic of several recent analyst reports. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a report on Monday, May 27th. UBS Group lifted their target price on shares of CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. Wells Fargo & Co lifted their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. Finally, Citigroup set a $202.00 target price on shares of CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $192.14.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What are the disadvantages of after-hours trading?
Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.